0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Heparin"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
Ischemic Stroke Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Ischemic Stroke Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
EUR$2,789USDGBP
From
EUR$4,850USDGBP
From
EUR$3,750USDGBP
From
EUR$2,490USDGBP
From
EUR$2,450USDGBP
From
EUR$2,850USDGBP
From
EUR$4,650USDGBP
Research Report on China's Heparin Export 2023-2032 - Product Thumbnail Image

Research Report on China's Heparin Export 2023-2032

  • Report
  • January 2023
  • 50 Pages
  • China
From
EUR$3,000USDGBP
Loading Indicator

Heparin is a type of anticoagulant drug used in the treatment of cardiovascular diseases. It is a naturally occurring anticoagulant, derived from the mucous membranes of animals, and is used to prevent the formation of blood clots. It is commonly used in the treatment of deep vein thrombosis, pulmonary embolism, and atrial fibrillation. It is also used to prevent clotting during hemodialysis and to prevent clotting during surgery. Heparin is available in both injectable and oral forms, and is typically administered in a hospital setting. It is also available in a variety of formulations, including low molecular weight heparin, unfractionated heparin, and fondaparinux. The cost of heparin varies depending on the formulation and the dosage. Heparin is a widely used anticoagulant in the cardiovascular drugs market. It is used in a variety of cardiovascular conditions, and is an important part of the treatment of many cardiovascular diseases. Some companies in the heparin market include Sanofi, Pfizer, Bristol-Myers Squibb, and GlaxoSmithKline. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more